{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:25:31Z","timestamp":1787635531533,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K16165"],"award-info":[{"award-number":["17K16165"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16370"],"award-info":[{"award-number":["21K16370"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.beem.2021.101601","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:59:45Z","timestamp":1637841585000},"page":"101601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Paraneoplastic autoimmune hypophysitis: An emerging concept"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-2714","authenticated-orcid":false,"given":"Hironori","family":"Bando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-9857","authenticated-orcid":false,"given":"Keitaro","family":"Kanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-9246","authenticated-orcid":false,"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2021.101601_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(98)85043-5","article-title":"Pituitary insufficiency","volume":"352","author":"Lamberts","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2021.101601_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib3","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2021.101601_bib4","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2021.101601_bib5","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/er.2016-1101","article-title":"Genetics of combined pituitary hormone deficiency: roadmap into the genome era","volume":"37","author":"Fang","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2021.101601_bib7","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1126\/science.1062736","article-title":"Pituitary development: regulatory codes in mammalian organogenesis","volume":"295","author":"Scully","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.beem.2021.101601_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(90)90067-O","article-title":"The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions","volume":"61","author":"Ingraham","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.beem.2021.101601_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/347528a0","article-title":"Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1","volume":"347","author":"Li","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.beem.2021.101601_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0303-7207(93)90097-4","article-title":"Analysis of Pit-1 in regulating mouse TSH beta promoter activity in thyrotropes","volume":"96","author":"Gordon","year":"1993","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0492-56","article-title":"Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene","volume":"1","author":"Tatsumi","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2021.101601_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature13573","article-title":"Required enhancer-matrin-3 network interactions for a homeodomain transcription program","volume":"514","author":"Skowronska-Krawczyk","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.beem.2021.101601_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.0.1490079","article-title":"Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions","volume":"149","author":"Raffin-Sanson","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00109-010-0651-0","article-title":"Alpha-melanocyte stimulating hormone: production and degradation","volume":"88","author":"D'Agostino","year":"2010","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.beem.2021.101601_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1043-2760(99)00213-1","article-title":"Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome","volume":"11","author":"Krude","year":"2000","journal-title":"Trends Endocrinol Metabol: TEM"},{"key":"10.1016\/j.beem.2021.101601_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12020-013-0127-4","article-title":"Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database","volume":"47","author":"Tanriverdi","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2021.101601_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2021.101601_bib18","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1530\/EJE-17-0009","article-title":"Mechanisms in endocrinology: hypophysitis: diagnosis and treatment","volume":"179","author":"Joshi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ecl.2014.10.011","article-title":"Hypophysitis","volume":"44","author":"Fukuoka","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2021.101601_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00318578","article-title":"Hypophysitis in surgical and autoptical specimens","volume":"90","author":"Sautner","year":"1995","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.beem.2021.101601_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02739954","article-title":"Lymphocytic hypophysitis: light and electron microscopic findings and correlation to clinical appearance","volume":"9","author":"Fehn","year":"1998","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2021.101601_bib22","first-page":"288","article-title":"Antipituitary antibodies in patients with lymphocytic hypophysitis","volume":"55","author":"Takao","year":"2001","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2021.101601_bib23","first-page":"609","article-title":"Cytosolic autoantigens in lymphocytic hypophysitis","volume":"83","author":"Crock","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1530\/eje.0.1470767","article-title":"Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis","volume":"147","author":"Tanaka","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03347415","article-title":"Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies","volume":"30","author":"Bensing","year":"2007","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2021.101601_bib26","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/jc.2013-2411","article-title":"Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells","volume":"98","author":"Iwama","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.5046","article-title":"Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis","volume":"244","author":"Yasuda","year":"2018","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.beem.2021.101601_bib28","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1210\/jc.2014-4209","article-title":"Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis","volume":"100","author":"Iwama","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib29","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(87)90592-7","article-title":"Autoantibodies to pituitary corticotropin-producing cells: possible marker for unfavourable outcome after pituitary microsurgery for Cushing's disease","volume":"1","author":"Scherbaum","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2021.101601_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000179516","article-title":"Pituitary autoimmunity","volume":"16","author":"Pouplard","year":"1982","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2021.101601_bib31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2021.101601_bib32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2021.101601_bib33","first-page":"8341426","article-title":"Update on pathophysiology, treatment, and complications of carcinoid syndrome","volume":"2020","author":"Clement","year":"2020","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.beem.2021.101601_bib34","article-title":"Adrenal insufficiency in immunochemotherapy for small-cell lung cancer with ectopic ACTH syndrome","volume":"2021","author":"Nakajima","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.beem.2021.101601_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2021.101601_bib36","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19871101)60:9<2275::AID-CNCR2820600929>3.0.CO;2-3","article-title":"Neurologic disorders in patients with small cell lung cancer","volume":"60","author":"Sculier","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2021.101601_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-0172(98)80039-5","article-title":"Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature","volume":"28","author":"Levy","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2021.101601_bib38","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.410370705","article-title":"Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies","volume":"37","author":"Latov","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.beem.2021.101601_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/B978-0-7020-4088-7.00078-X","article-title":"Paraneoplastic disorders of the central and peripheral nervous systems","volume":"121","author":"Didelot","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.beem.2021.101601_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","article-title":"Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells","volume":"321","author":"Thirkill","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2021.101601_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1521-4141(200102)31:2<563::AID-IMMU563>3.0.CO;2-D","article-title":"Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome","volume":"31","author":"Maeda","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.beem.2021.101601_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-510X(98)00257-3","article-title":"Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody","volume":"161","author":"Tanaka","year":"1998","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.beem.2021.101601_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(99)00029-5","article-title":"Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody","volume":"163","author":"Tanaka","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.beem.2021.101601_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mus.25027","article-title":"P\/Q- and N-type calcium-channel antibodies: oncological, neurological, and serological accompaniments","volume":"54","author":"Zalewski","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.beem.2021.101601_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2021.101601_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beem.2021.101601_bib47","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-19-1051","article-title":"Mechanisms in endocrinology: autoimmune hypopituitarism: novel mechanistic insights","volume":"182","author":"Takahashi","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI44073","article-title":"Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans","volume":"121","author":"Yamamoto","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2021.101601_bib49","first-page":"290","article-title":"Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism","volume":"12","author":"Bando","year":"2015","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.beem.2021.101601_bib50","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ecl.2009.01.001","article-title":"Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism","volume":"38","author":"Brown","year":"2009","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2021.101601_bib52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis","volume":"25","author":"Cavalcante","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.beem.2021.101601_bib53","doi-asserted-by":"crossref","first-page":"E1744","DOI":"10.1210\/jc.2014-1769","article-title":"Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome","volume":"99","author":"Bando","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(02)00338-2","article-title":"Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention","volume":"17","author":"Liblau","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.beem.2021.101601_bib55","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1210\/js.2019-00243","article-title":"Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells","volume":"3","author":"Kanie","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.beem.2021.101601_bib56","doi-asserted-by":"crossref","first-page":"43060","DOI":"10.1038\/srep43060","article-title":"A\u00a0novel thymoma-associated autoimmune disease: anti-PIT-1 antibody syndrome","volume":"7","author":"Bando","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101601_bib57","doi-asserted-by":"crossref","first-page":"bvaa194","DOI":"10.1210\/jendso\/bvaa194","article-title":"Two cases of anti-PIT-1 hypophysitis exhibited as a form of paraneoplastic syndrome not associated with thymoma","volume":"5","author":"Kanie","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.beem.2021.101601_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1272\/jnms.84.201","article-title":"Review on recent topics in hypophysitis","volume":"84","author":"Sugihara","year":"2017","journal-title":"J\u00a0Nippon Med Sch = Nippon Ika Daigaku zasshi"},{"key":"10.1016\/j.beem.2021.101601_bib59","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41388-017-0036-8","article-title":"Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis","volume":"37","author":"Martinez-Ordo\u00f1ez","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2021.101601_bib60","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1172\/JCI42015","article-title":"Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis","volume":"120","author":"Ben-Batalla","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2021.101601_bib61","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101601_bib62","first-page":"315","article-title":"DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma","volume":"56","author":"Kishibuchi","year":"2020","journal-title":"Int J Oncol"},{"key":"10.1016\/j.beem.2021.101601_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","article-title":"Aberrant methylation of tumour-related genes in thymic epithelial tumours","volume":"64","author":"Hirose","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.beem.2021.101601_bib64","first-page":"2762","article-title":"Genome-wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes","volume":"41","author":"Bi","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.beem.2021.101601_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122121","article-title":"Gene-specific methylation analysis in thymomas of patients with myasthenia gravis","volume":"17","author":"Lopomo","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2021.101601_bib66","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J\u00a0Thorac Oncol: Off Publ Int Ass Stud Lung Cancer"},{"key":"10.1016\/j.beem.2021.101601_bib67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.beem.2021.101601_bib68","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"\u00c1lvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"10.1016\/j.beem.2021.101601_bib69","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.4103\/2230-8210.84865","article-title":"Adult growth hormone deficiency","volume":"15","author":"Gupta","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12477","article-title":"Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity","volume":"81","author":"van Bunderen","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101601_bib72","first-page":"111","article-title":"Heterogeneity of anterior pituitary cell antibodies detected in insulin-dependent diabetes mellitus and adrenocorticotropic hormone deficiency","volume":"3","author":"Sugiura","year":"1986","journal-title":"Diabetes Res"},{"key":"10.1016\/j.beem.2021.101601_bib73","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1210\/jcem-70-5-1391","article-title":"Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides","volume":"70","author":"Sauter","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101601_bib74","doi-asserted-by":"crossref","first-page":"578802","DOI":"10.3389\/fendo.2021.578802","article-title":"Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic hormone deficiency","volume":"12","author":"Fujita","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib75","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11102-018-0901-7","article-title":"Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome","volume":"21","author":"Bando","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101601_bib76","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2169\/internalmedicine.48.1972","article-title":"Type 2 diabetes mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer","volume":"48","author":"Kamiya","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.beem.2021.101601_bib77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1752-1947-8-90","article-title":"Isolated adrenocorticotropic hormone deficiency development during chemotherapy for gastric cancer: a case report","volume":"8","author":"Kinoshita","year":"2014","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.beem.2021.101601_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2169\/internalmedicine.36.819","article-title":"Acute lymphoblastic leukemia with isolated adrenocorticotropic hormone deficiency","volume":"36","author":"Yamaguchi","year":"1997","journal-title":"Intern Med (Tokyo)"},{"key":"10.1016\/j.beem.2021.101601_bib79","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13277-014-2784-1","article-title":"Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer","volume":"36","author":"Hao","year":"2015","journal-title":"Tumour Biol: J Int Soc Oncodevelopmental Biol Med"},{"key":"10.1016\/j.beem.2021.101601_bib80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/eje.1.02077","article-title":"RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome","volume":"154","author":"Messager","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101601_bib81","series-title":"Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome","author":"Kanie","year":"2021"},{"key":"10.1016\/j.beem.2021.101601_bib82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1634\/theoncologist.2018-0470","article-title":"Endocrine-related adverse events related to immune checkpoint inhibitors: proposed algorithms for management","volume":"25","author":"Del Rivero","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.beem.2021.101601_bib83","doi-asserted-by":"crossref","first-page":"230ra45","DOI":"10.1126\/scitranslmed.3008002","article-title":"Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody","volume":"6","author":"Iwama","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beem.2021.101601_bib84","series-title":"Isolated adrenocorticotropin deficiency due to nivolumab-induced hypophysitis in a patient with advanced lung adenocarcinoma: a case report and literature review","author":"Ohara","year":"2017"},{"key":"10.1016\/j.beem.2021.101601_bib85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/js.2017-00414","article-title":"Two cases of atezolizumab-induced hypophysitis","volume":"2","author":"Kanie","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.beem.2021.101601_bib86","doi-asserted-by":"crossref","first-page":"152009","DOI":"10.1016\/j.imbio.2020.152009","article-title":"The role of macrophages type 2 and T-regs in immune checkpoint inhibitor related adverse events","volume":"225","author":"Mihic-Probst","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.beem.2021.101601_bib87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.beem.2021.101601_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.det.2007.08.002","article-title":"Cutaneous manifestations of internal malignancies: an overview","volume":"26","author":"Pipkin","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.beem.2021.101601_bib89","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1507\/endocrj.K08E-146","article-title":"Prevalence of maturity-onset isolated ACTH deficiency (IAD) in 2005: Japanese cohort studies","volume":"55","author":"Yamamoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2021.101601_bib90","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","article-title":"Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma","volume":"342","author":"Beuschlein","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2021.101601_bib91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198501033120103","article-title":"Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor","volume":"312","author":"Melmed","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2021.101601_bib92","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00508-015-0775-x","article-title":"Ectopic acromegaly due to a growth hormone-secreting neuroendocrine-differentiated tumor developed from ovarian mature cystic teratoma","volume":"127","author":"Ozkaya","year":"2015","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.beem.2021.101601_bib93","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1089\/thy.2012.0574","article-title":"Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature","volume":"23","author":"Tong","year":"2013","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"10.1016\/j.beem.2021.101601_bib94","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1210\/endo-122-6-2508","article-title":"A\u00a0human B-lymphoblastoid cell line produces prolactin","volume":"122","author":"DiMattia","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2021.101601_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-12-5","article-title":"POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)","volume":"12","author":"Lisboa","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.beem.2021.101601_bib96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.5324","article-title":"POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages","volume":"249","author":"Seoane","year":"2019","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.beem.2021.101601_bib97","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1038\/s41388-021-01740-6","article-title":"POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation","volume":"40","author":"Mart\u00ednez-Ordo\u00f1ez","year":"2021","journal-title":"Oncogene"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:08Z","timestamp":1761497948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1521690X21001184"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101601","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic autoimmune hypophysitis: An emerging concept","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101601"}}